Editor(s):
(1) Prof. Antonio Mastino, University of Messina, Institute of Translational Pharmacology, Italy.
(2) Dr. Takashi Ikeno, National Cancer Center Hospital East, Japan.
Reviewers:
(1) Alopoudi Aristi, Aristotle University of Thessaloniki, Greece.
(2) Kerem Kemik, Dokuz Eylül University, Turkey.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7.75/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Alopoudi Aristi, Greece) | File 1 | NA
Stage 2 | Peer Review Report_2 (Kerem Kemik, Turkey) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA